GCG and Alzheimer disease: After only two weeks of oxycodone treatment in mice with established CKD, there were not notable differences in bone structural parameters beyond expected changes due to CKD except for trabecular bone volume a 14% lower in AD + OXY than untreated adenine, but only statistically lower than both CON groups.